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Departments of Medicine and Physiology, University of California, San Francisco, CaliforniaABSTRACT Tetramers of aquaporin-4 (AQP4) water channels form supramolecular assemblies in cell membranes called
orthogonal arrays of particles (OAPs). We previously reported evidence that a short (M23) AQP4 isoform produced by alterna-
tive splicing forms OAPs by an intermolecular N-terminus interaction, whereas the full-length (M1) AQP4 isoform does not by
itself form OAPs but can coassemble with M23 in OAPs as heterotetramers. Here, we developed a model to predict number
distributions of OAP size, shape, and composition as a function M23:M1 molar ratio. Model specifications included: random
tetrameric assembly of M1 with M23; intertetramer associations between M23 and M23, but not between M1 and M23 or M1;
and a free energy constraint limiting OAP size. Model predictions were tested by total internal reflection fluorescencemicroscopy
of AQP4-green-fluorescent protein chimeras and native gel electrophoresis of cells expressing different M23:M1 ratios. Exper-
imentally validated model predictions included: 1), greatly increased OAP size with increasing M23:M1 ratio; 2), marked hetero-
geneity in OAP size at fixed M23:M1, with increased M23 fraction in larger OAPs; and 3), preferential M1 localization at the
periphery of OAPs. The model was also applied to test predictions about binding to AQP4 OAPs of a pathogenic AQP4 auto-
antibody found in the neuroinflammatory demyelinating disease neuromyelitis optica. Our model of AQP4 OAPs links a molec-
ular-level interaction of AQP4 with its supramolecular assembly in cell membranes.INTRODUCTIONAquaporin-4 (AQP4) is a water channel expressed at the
plasma membrane in astrocytes throughout the central
nervous system, as well as in peripheral organs including
kidney tubules, airway epithelium, skeletal muscle, and
gastric parietal cells (1,2). In brain, AQP4 is involved in
water balance, neuroexcitation, astrocyte migration, and
neuroinflammation (3–7). AQP4 is also implicated in the
multiple sclerosis-like disease neuromyelitis optica
(NMO), where pathogenic autoantibodies against AQP4
(NMO-IgG) cause neuroinflammation and demyelination,
leading to paralysis and blindness (8–10).
Human AQP4 protein is expressed as two isoforms, a full-
length, long (M1) isoform with translation initiation at
Met-1, and a shorter (M23) isoform produced by alternative
splicing with translation initiation at Met-23 (11–13). We
discovered that M23 AQP4 forms supramolecular assem-
blies called orthogonal arrays of particles (OAPs) (14),
which are square arrays of particles visualized by freeze-
fracture electron microscopy (FFEM) in brain, kidney,
skeletal muscle, and other tissues (15–18). Though the M1
isoform by itself does not form OAPs, M1 can coassemble
with M23 in arrays, producing smaller OAPs than those
formed by M23 alone (19,20). We reported evidence, by
quantum dot single particle tracking, single molecule photo-
bleaching, and blue-native gel electrophoresis, that M1 and
M23 can associate in heterotetramers (21,22), which could
explain the observation that M1 incorporates into M23-con-
taining OAPs, but does not by itself form OAPs (19). At theSubmitted March 17, 2011, and accepted for publication May 9, 2011.
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0006-3495/11/06/2936/10 $2.00molecular level, we found by truncation and mutagenesis
analysis that OAP formation by M23 involves an intermo-
lecular N-terminus interaction between two M23 molecules
by residues just downstream of Met-23, and that the
inability of M1 by itself to form OAPs is due to blocking
of the N-terminal interaction by residues just upstream of
Met-23 (23).
Here, we developed a mathematical model of AQP4 OAP
assembly to test our experimental evidence-based ideas
about M23 association and M1/M23 heterotetramer forma-
tion. The model provides quantitative insight into the role of
M1/M23 composition in OAP assembly, and made predic-
tions about OAP topography and composition that were
tested experimentally by biophysical and biochemical
measurements on M1/M23-transfected cells. The model
inputs included M1:M23 molar ratio, association rules,
and free energy constraints, and the model outputs included
number distributions of OAP size and shape, and total/
perimeter M1/M23 composition. The association rules for
the initial model included random M1/M23 association in
heterotetramers and monovalent M23-M23 intermolecular
association.
Fig. 1 illustrates the idea. Individual AQP4 tetramers
contain zero, one, two, three, or four M1 monomers, in six
possible independent configurations (with rotation possible)
(Fig. 1 A). If tetramer-tetramer association requires at least
one intertetrameric M23-M23 interaction, then many OAP
configurations are possible of different size, shape, and
composition. Conceptually, more M1 at fixed M23 is pre-
dicted to reduce OAP size because M1 blocks tetramer asso-
ciations by coating the outer surface of OAPs (Fig. 1 B). The
modeling here involved the serial generation of AQP4doi: 10.1016/j.bpj.2011.05.012
FIGURE 1 Schematic of OAP assembly from AQP4 M1/M23 heterote-
tramers. (A) (top) M23 and M1 AQP4 monomers. Projection from M23
monomer denotes potential site of M23-M23 intertetrameric interaction.
(bottom) Six possible independent AQP4 M1/M23 heterotetramers. Four-
way rotational variants of each are possible as well. (B) Examples of
OAPs at low and high M23:M1 ratios.
AQP4 Orthogonal Arrays of Particles 2937tetramers whose M1/M23 composition was determined
using random numbers (for each monomer) and the speci-
fied M1:M23 ratio. Newly generated AQP4 tetramers were
then appended to an existing OAP until no more tetramers
could be added, at which point mature OAPs were analyzed
for size, shape, and M1/M23 composition for number histo-
gram generation (Movie S1, Supporting Material). Specified
association rules and free energy constraints were applied at
the step of appending newly generated tetramers.EXPERIMENTAL PROCEDURES
Constructs and cell transfections
The cDNA constructs encoding human M1 and M23 AQP4 were poly-
merase chain reaction-amplified using human brain cDNA as template.
M1 and M23 AQP4-green-fluorescent protein (GFP) chimeras, with GFP
appended to the AQP4 C terminus, were generated as described (22).
Polymerase chain reaction fragments were ligated into mammalian expres-
sion vector pcDNA3.1 (Invitrogen, Carlsbad, CA). Constructs were fully
sequenced. U87MG cells (human glioblastoma-astrocytoma, ATCC
HTB-14) were cultured at 37C in 5% CO2, 95% air in appropriate medium
containing 10% fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml
streptomycin. Cells were transfected in antibiotic-free medium 12–24 h
before the experiments using FuGene HD (Roche, Basel, Switzerland) at
a 3:1 ratio (ml/mg DNA, 0.18 mg DNA/cm2 culture). In various experiments
different ratios of plasmids encoding the untagged or GFP-tagged M1 and
M23 AQP4 constructs were used.Electrophoresis and immunoblot analysis
Imidazole, g-aminocaproic acid, Triton X-100, Tricine, and ferritin were
purchased from Sigma (St. Louis, MO), and acrylamide/bisacrylamide
and Coomassie Blue G-250 from Serva (Heidelberg, Germany). Large
pore polyacrylamide native gradient gels (2–9%) were prepared as
described (24). Cell cultures were lysed with Blue Native buffer (25)
containing Triton X-100 (detergent/protein ratio of 4.0 g/g). Lysates
were centrifuged at 20,000  g for 20 min at 4C and the pellet dis-
carded. Samples (10 mg protein) were mixed with 5% Coomassie Blue
G-250 and loaded into each lane. Ferritin was used as the molecular
mass standard (440 and 880 kDa). The running buffers were 25 mMimidazole, pH 7 (anode buffer), and 50 mM Tricine, 7.5 mM imidazole,
0.02% Coomassie Blue G-250, pH 7 (cathode buffer). Proteins were
blotted onto polyvinylidene difluoride membranes (Millipore, Bedford,
MA) for immunoblot analysis using a native transfer buffer (50 mM
Tricine, 7.5 mM imidazole). For the second dimension, lanes from the
first dimension were cut into individual strips and equilibrated in
denaturation buffer (1% sodium dodecyl sulfate (SDS), 1% b-mercaptoe-
thanol) for 1–2 h at room temperature. A single strip was then placed
into a second dimension gel of the same thickness and subjected to
Tricine SDS-polyacrylamide gel electrophoresis (PAGE) using standard
protocol (25).
For one-dimensional Laemmli SDS-PAGE, gels consisted of a 12%
running gel and 3% stacking gel. Samples were not heated before loading.
SeeBlue Plus2 Pre-Stained Standard (Invitrogen, Carlsbad, CA) was used
as molecular weight markers. Proteins were blotted onto polyvinylidene
-difluoride membranes at 160 mA for 1.5 h using a TGE-SDS buffer:
1.92 M glycine, 0.25 M Tris base, 10 mM EDTA, 1% SDS. For immunoblot
analysis, membranes were blocked with 3% bovine serum albumin and
incubated with rabbit anti-AQP4 (Santa Cruz Biotech, Santa Cruz, CA) at
room temperature for 2 h. Membranes were then rinsed, incubated for
1 h with horseradish peroxidase-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA), rinsed extensively, and
labeled proteins were detected using the ECL Plus enzymatic chemilumi-
nescence kit (Amersham Biosciences, Pittsburgh, PA).Total internal reflection fluorescence microscopy
Total internal reflection fluorescence (TIRF) microscopy was done on
a Nikon Eclipse TE2000E microscope equipped with infrared autofocus,
100, 1.49 numerical aperture Apo TIRF objective, Nikon TIRF attach-
ment, Photometrics QuantEM 512SC charge-coupled device (CCD)
camera, and Spectra-Physics Advantage 161C 10 milliwatt argon ion laser
(coupled to fiber optic via a quarter wave plate). Filters included a Z488/
10 excitation filter, Z488RDC dichroic mirror, and ET525/50 m emission
filter (Chroma, Bellows Falls, VT). For imaging, cells were grown on
18-mm-diameter coverglasses, mounted in a custom chamber with phos-
phate buffered saline containing 6 mM glucose and 1.1 mM sodium pyru-
vate, and maintained at 37C by a Harvard Apparatus microincubator.
Images were acquired using identical CCD settings in the central region
(~20  20 mm) of the CCD chip. Image processing, as described (22,26),
was done to generate number histograms of background-subtracted, area-
integrated fluorescence intensities from fluorescent spots. Intensities were
referenced to monomeric recombinant GFP.NMO-IgG binding to AQP4
Binding of a monoclonal recombinant antibody (rAb-53, (21,27)) was
measured to U87MG cells expressingM1 andM23 AQP4 at specified molar
ratios using a quantitative ratio imaging method as described (28,29).
Briefly, cells were incubated for 60 min with rAb-53 at 50 mg/ml, washed,
permeabilized, and then incubated with an antibody against the common (to
M1 and M23) AQP4 C-terminus. Using secondary antibodies r53-Ab was
stained green and total AQP4 red. Measured green/red fluorescence ratio
(background-subtracted) was taken as a quantitative measure of NMO-IgG
binding to AQP4.MATHEMATICAL MODEL
The mathematical model as diagrammed in Fig. 2 contains
three components: tetramer generation; OAP generation;
and OAP characterization. The model was programmed
using MATLAB 7.0 (The MathWorks, Natick, MA), which
facilitated matrix manipulations and image processing. ForBiophysical Journal 100(12) 2936–2945
FIGURE 2 Schematic of modeling approach.
See Mathematical Model section for description.
2938 Jin et al.tetramer generation, the M1 versus M23 identities of each of
the four monomers/tetramer were determined randomly
from specified M23:M1 molar ratio, using a random number
from 0 to 1 with threshold specified from the M23:M1 ratio.
AQP4 tetramers were generated serially, generally>10,000/
computation, to give robust predictions that were insensitive
to a generation of more tetramers (typical error <1%).
Matrix operations were done for OAP generation to asso-
ciate newly generated tetramers to a nascent OAP. M23 and
M1 are represented by numbers 1 and 0, respectively,
according to the association rule that only M23-M23 inter-
action can occur. Each tetramer is represented by a 2  2
matrix (for example, tetramer with three M23 and one M1
is described by the 2 2 matrix, T¼ [1 1; 1 0]. The tetramer
can be rotated at the binding site, with tetramer rotation ex-Biophysical Journal 100(12) 2936–2945pressed by rot90(T, k) (k¼ 0, 1, 2, and 3, respectively, for 0,
90, 180, and 270 degree rotations). If a newly generated
tetramer is composed of pure M1, then the tetramer is
counted as an OAP of unity size and another tetramer is
generated. A nascent OAP, containing many AQP4 tetra-
mers is represented by an N  N matrix, with each potential
binding site at the periphery of the OAP by a 2  2 matrix.
At each tetramer-OAP association step, an association score
at each binding site was computed by multiplication of the
tetramer and binding site matrices. Additional details are
provided in the Supporting Material.
In the first-generation nonconstrained models, tetramer
generation and tetramer-OAP association was repeated until
all OAP binding sites were occupied. In model I-a (optimal-
association model), the site of tetramer association was
AQP4 Orthogonal Arrays of Particles 2939determined by maximum association score (valency). In
model I-b (random-association model), the binding site
was selected randomly without regard to (nonzero) associa-
tion score. In model I-c (self-association model), association
was allowed only when tetramers contained one or three
M23 monomers. In the second-generation constrained
model OAP growth and completion was determined both
by M1 blocking (as in the first-generation models) but
also by a free energy constraint. Positive free energy
(PSE) was computed as the total number of M23-M23
associations, and negative free energy (NFE) was computed
semiempirically to reproduce experimentally measured
OAP sizes (described below, see Fig. 5 A). The free energy
constraint was applied at each tetramer addition step, allow-
ing tetramer-OAP association when PFE < NFE. OAP
completion occurs when all the binding sites are blocked
by M1 or when PFE < NFE, even if all binding sites are
not blocked by M1.FIGURE 3 Predictions of first-generation OAP model. The model
assumes random M1 and M23 association in heterotetramers, and monova-
lent intertetrameric M23-M23 interactions. (A) Gallery of OAPs generated
for 1:1 M23:M1 molar ratio (left). Example of heterotetramer (top right),
and of very large OAP for 4:1 M23:M1 ratio (bottom right). (B and C)
Number histograms of the distribution of OAP size (B) and content (fraction
M23) (C) at indicated M23:M1. There were>10,000 tetramers generated/
condition.RESULTS
Our model assumes random association of M1 and M23
AQP4 monomers in homotetramers or heterotetramers
(Fig. 1 A) and that intermolecular M23-M23 associations
promote OAP formation, whereas intermolecular M1-M23
and M1-M1 interactions are insignificant. As such,
increased M1 relative to M23 reduces mean OAP size as
depicted in Fig. 1 B. As summarized in Fig. 2, the modeling
computation involved serial generation of a large number of
AQP4 tetramers whose composition was determined by
random numbers in which the specified molar M23:M1 ratio
was applied using threshold conditions. Newly generated
tetramers were rotated and translated to select a suitable
site for binding to a nascent OAP (Movie S1). If the OAP
is unable to accommodate additional AQP4 tetramers it
was considered completed, and analyzed for size, shape,
and total/peripheral M23:M1 content. The AQP4 tetra-
mers/OAP generation process was continued to specified
statistical endpoints.
General features of the model were explored from initial
computations done with the minimal assumptions of random
heterotetrameric M1 and M23 AQP4 association and ener-
getically optimal AQP4 tetramer binding to nascent OAPs
(binding prioritization dictated by valency) (model I-a).
Fig. 3 A shows a gallery of generated OAPs at an
M23:M1 ratio of 1:1. Generally, OAPs consisted of
a M23-rich core with M1 monomers decorating the
periphery, which limits OAP size by preventing further
binding of AQP4 tetramers. Individual AQP4 tetramers con-
taining four M1 monomers (OAP size ¼ 1) were generated
as well. There was considerable heterogeneity in OAP size
and shape at fixed M23:M1, which has been seen for
OAPs in cell membrane by freeze-fracture electron micros-
copy (FFEM) (19,20). OAPs with internal defects (holes)
were also occasionally generated by the model (Fig. 3 A,bottom right), resembling those seen in published freeze-
fracture electron micrographs (19,20,30,31). Increased
M23:M1 ratio predicts OAPs of larger size, with one
example of a very large OAP shown in Fig. 3 A (bottom
right). Fig. 3 B shows number histograms of OAP size, as
quantified by the number of tetramers per OAP, at different
M23:M1 ratios. Increased M23:M1 ratio produced OAPs of
greater average size, with considerable size heterogeneity
seen at intermediate M23:M1 ratios. Fig. 3 C shows number
histograms of OAP composition, quantified as the fraction
of M23 monomers (to total AQP4 monomers) in each
OAP. Increased M23:M1 produced OAPs with increased
average M23 content, as expected, and with considerable
heterogeneity in M23 content, particularly at a low
M23:M1 ratio. As reported below, these general features
of the model were robust, insensitive to model details, and
verified experimentally.
Fig. 4 A summarizes the average OAP size as predicted
for the first-generation model above (solid circles). OAP
size increased remarkably with an increasing M23:M1 ratio.
Some OAPs grow without bound at M23:M1 > 1:1, and
>90% of OAPs grow without bound at M23:M1 > 2:1.
Unrestricted OAP growth at high M23:M1 is not the caseBiophysical Journal 100(12) 2936–2945
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FIGURE 4 OAP size predictions of first-genera-
tion non-constrained models. (A) Average OAP
size (number of AQP4 tetramers/OAP) as a func-
tion of the M23:M1 ratio for three variations
(a-c) of nonconstrained first-generation models
(mean 5 SD). Open circles and triangle are from
published freeze-fracture electron micrographs
(19,30). (B) Number histograms of the distribution
of OAP size for models I-a, I-b, and I-c at M23:M1
ratios of 1:20, 2:3, and 1:1.
2940 Jin et al.in reality, with experimentally measured average OAP sizes
deduced from FFEM (19,30) shown in Fig. 4 A.
Several variations of the first-generation model were im-
plemented to investigate the sensitivity of model predictions
to the rules of tetramer association and to attempt to repro-
duce experimentally measured OAP size at high M23:M1.
In one variation of the first-generation model (model I-b,
random-association model), the assumption of energetically
optimal AQP4 tetramer binding to nascent OAPs was
relaxed so that generated AQP4 tetramers bind at random
on the OAP (nonenergetically optimized). Predictions of
model I-b for M23:M1-dependent average OAP size
(Fig. 4 A) and size distribution (Fig. 4 B) were very similar
to those of model I-a (optimal-association model). In
another model variation (model I-c, self-association model),
AQP4 tetramer association was allowed only when tetra-
mers contained one or three M23 monomers, reasoning
that intertetrameric M23-M23 associations might be pre-
vented for two M23 monomers in a tetramer if an intratetra-
meric association occurs. Though model I-c mildly reduced
OAP size (Fig. 4, A and B), it was also unable to reproduce
experimentally measured OAP sizes. In each of the three
variations of the nonconstrained model, the general model
predictions, including greatly increased OAP size with
increasing M23:M1 ratio and preferential localization of
M1 to the OAP periphery, were insensitive to the details
of model assumptions. Similar findings were obtained
with other model I variations, including inclusion of repul-
sive M1-M1 and/or M1-M23 interactions (not shown).
A second-generation model was developed in which
a free energy constraint was applied to reproduce experi-
mentally measured M23:M1-dependent OAP sizes. There
are multiple determinants of OAP free energy that are not
considered in the first-generation models, which are likely
to be involved in limiting OAP size at a fixed M23:M1 ratio.
For example, though the addition of one AQP4 tetramer to
a nascent OAP is energetically favorable because of M23-
M23 interaction(s), it is entropically unfavorable becauseBiophysical Journal 100(12) 2936–2945of reduced translational and rotational freedom of the
enlarged OAP compared to the original OAP and the free
AQP4 tetramer. In addition, there are energetic barriers,
such as membrane curvature, that limit OAPs size, as well
as membrane crowding effects, and AQP4-lipid and
AQP4-(non-AQP4) protein interactions. Because these
factors cannot be quantified, we lump them together as
a single negative free energy parameter.
A semiempirical approach was used to apply free energy
constraints in the second-generation OAP model. As shown
in Fig. 5 A, PFE was computed as the number of M23-M23
interactions/OAP, which increases with OAP size and
M23:M1 ratio. NFE was taken as a curvilinear (2-parameter
power law) function of OAP size as constrained by experi-
mentally measured OAP sizes. The free energy constraint
was applied as a decision point after each AQP4 tetramer
binding event in a growing OAP, in which further OAP
growth was allowed only for PFE > NFE (Fig. 2). Fig. 5
B shows representative OAPs generated using the second-
generation model. The OAPs were smaller than those in
first-generation models, but preserved the general features
of M23:M1 ratio-dependent OAP size, composition, and
peripheral M1 localization. Fig. 5 C shows that the predicted
average OAP sizes determined using the empirically derived
NFE function agreed with experimental data.
Fig. 5, D–F shows number histograms of OAP size,
shape, and peripheral OAP composition for different
M23:M1 ratios. Average OAP size, as well as OAP size
heterogeneity, increased with M23:M1 ratio (Fig. 5 D).
OAP shape was quantified by a shape parameter that was
computed as the ratio of monomers at the periphery to the
square root of the total number of monomers in total area.
An S-value of unity indicates a square array, with S > 1
signifying more elongated and complex arrays as depicted
in Fig. 5 E (right). OAPs were generally more elongated
with a reduced M23:M1 ratio. Peripheral OAP composition,
expressed as the fraction M1 at the boundary to that in the
total OAP, shows reduced M1 fraction at the boundary
FIGURE 5 Second-generation, free energy-con-
strained OAP model. (A) Free energy versus OAP
size relation. Positive free energy (M23-M23 inter-
actions/OAP) as a function of OAP size computed
for indicated M23:M1. Empirically determined
negative free energy (red), which constrains OAP
size. (B) Gallery of OAPs generated by the model
at indicated M23:M1 ratio. (C) Computed average
OAP size (mean5 SD) as a function of M23:M1
ratio for the second-generation model (solid trian-
gles), shown with experimental data (open circles
and triangle). (D–F) Number histograms of the
distribution of OAP size (D), shape (E), and
boundary composition (F) at indicated M23:M1
ratios. OAP size quantified as number of tetramers;
OAP shape as the ratio of monomers at the
periphery to the square root of the total number
of monomers (examples of OAPs with different
shaped parameters shown in panel E, right); and
content as the fraction M1 at the boundary to the
fraction M1 throughout the OAP.
AQP4 Orthogonal Arrays of Particles 2941with greater M23:M1 ratio, which is a consequence of the
NFE constraint that limits OAP size independent of periph-
eral M1 accumulation.
Key predictions of the model were tested experimentally
by biophysical and biochemical measurements on cells
expressing AQP4 at defined M23:M1 ratios. The size of
AQP4 aggregates, representing OAPs, and the M1/M23
spatial distribution were determined by total internal reflec-
tion fluorescence microscopy in cells expressing GFP-AQP4
chimeras. In one set of experiments cells were transfected
with GFP-M1 and GFP-M23 AQP4 at different ratios under
conditions of low expression to enable visualization of indi-
vidual fluorescent spots, each representing a single AQP4
aggregate or tetramer. AQP4 aggregate size was deduced
from spot-integrated fluorescence intensities referenced to
GFP standards, as done previously (22,26). Fig. 6 A shows
total internal reflection fluorescence microscopy images(top) and number histograms (bottom) of (background-sub-
tracted) single spot fluorescence in U87MG cells expressing
GFP-M23 and GFP-M1 at specified ratios. The number
histogram showed ~4-fold greater intensity of individual
M1 tetramers than monomeric GFP, as expected. Higher
spot fluorescence intensities, corresponding to larger
AQP4 aggregates (OAPs), were seen at greater M23:M1
ratios, with considerable heterogeneity seen at all ratios.
In a second set of experiments cells were transfected with
GFP-M1 and (untagged) M23 AQP4 to visualize the spatial
distribution of M1 AQP4. Experiments were done at high
M23:M1 to generate large OAPs of size greater than the
TIRF x,y-resolution (diffraction limit). Fig. 6 B (left) shows
high magnification TIRF micrographs of two large AQP4
aggregates in which GFP-M1 fluorescence was greater at
the periphery than at the center, as confirmed by line scans
(Fig. 6 B, right).Biophysical Journal 100(12) 2936–2945
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FIGURE 6 Experimental measurements of OAP
properties and NMO-IgG/AQP4 binding. (A)
U87MG cells were transfected with GFP-M23
and GFP-M1 AQP4 at indicated ratios. Representa-
tive TIRF micrographs show fluorescent spot (top).
Deduced number histograms of single spot fluores-
cence (background-subtracted, area-integrated
intensities), proportional to AQP4 aggregate
(OAP) size, shown at the bottom. Unity represents
the intensity of monomeric GFP. (B) U87MG cells
were transfected with (untagged) M23 AQP4 and
GFP-M1 AQP4 and at a ratio of 20:1. Representa-
tive TIFR micrographs of large AQP4 aggregate
(left) show relative concentration of fluorescence
at the periphery. Line profiles (dashed white lines
at the left) shown at the right. (C) AQP4 immuno-
blot after SDS/PAGE (inset) and BN-SDS/PAGE of
lysates from U87MG cells expressing (untagged)
M1 and M23 AQP4 at indicated ratios. (D)
NMO-IgG binding to AQP4 OAPs. U87MG cells
expressing M1 and M23 AQP4 (both untagged)
were stained with NMO-IgG (recombinant mono-
clonal antibody rAb-53(28)) and anti-AQP4 anti-
body as described under Experimental Procedures
section. Relative binding (normalized to unity at
M23:M1 ¼ N) measured by quantitative ratio
imaging (SE n ¼ 4) shown along with model-
predicted curve: relative binding ¼ 0.14 þ 0.86
[1-(1þa)-4], where a is the M23:M1 ratio;
[1-(1þa)-4] is the probability that an AQP4 mono-
mer is OAP-associated.
2942 Jin et al.The composition of AQP4 aggregates was assessed by
2-dimensional blue native (BN)-SDS/PAGE and immuno-
blot analysis in which M23 and M1 AQP4 in aggregates
of increasing relative sizes were visualized in the nondena-
turing direction (from right to left), exploiting differences in
molecular mass (in the denaturing direction) to identify M23
versus M1 AQP4 (Fig. 6 C). BN-PAGE is a semiquantitative
biochemical method to infer the presence of AQP4 aggre-
gates/OAPs (21,29,32). Because the membrane is solubi-
lized and the details of the banding pattern depend on
detergent conditions and dye binding properties, it is not
possible to assign distinct aggregate sizes to the various
bands or to make quantitative inferences about absolute
M23:M1 content (24). Notwithstanding this limitation,
however, the large pore BN-SDS/PAGE in Fig. 6 C shows
that M1 did not form aggregates on its own, as evidenced
by a single spot, and that coexpression of M23 with M1
produced multiple bands in the nondenaturing direction in
which the number and relative molecular size of the spots
increased with a greater M23:M1 ratio. The relative M23-
to-M1 amount was greater in the bands corresponding to
larger aggregates, as seen in the denaturing direction.
SDS/PAGE (Fig. 6 C, inset) confirmed relative M23-to-
M1 expression in cells transfected with different amounts
of the M23 versus M1 plasmids.
The model was also applied to investigate the binding
mechanism of a NMO autoantibody that recognizes 3-
dimensional extracellular epitopes on AQP4. For theseBiophysical Journal 100(12) 2936–2945measurements we used a recombinant monoclonal antibody,
rAb-53, that binds with greater affinity to OAP-assembled
AQP4 than to AQP4 in individual tetramers, which is typical
of NMO autoantibodies (28). The rAb-53 binding to AQP4
was measured by quantitative ratio imaging in cells express-
ing AQP4 at different M23:M1 ratios, in which antibody
binding was normalized to total membrane AQP4 by ratio
imaging fluorescence microscopy. Fig. 6 D shows increased
rAb-53 binding to AQP4 with an increasing M23:M1 ratio,
with 50% maximal effect at M23:M1 ~ 0.2. The experi-
mental data fitted well to the model curve based on the
simple assumption that rAb-53 binds to (non-OAP-associ-
ated) M1 AQP4 tetramers with low affinity, and to OAPs
with relatively high (OAP-size-independent) affinity.DISCUSSION
Our model of AQP4 OAP assembly served several purposes.
First, as constrained by experimental data on OAP size as
a function of AQP4M23:M1 ratio, it established a minimum
set of rules required to reproduce the major topographic and
compositional features of OAPs in cell membranes. As such,
the model provided insight into how the AQP4 N-terminus
M23-M23 intermolecular interaction translates to assembly
of OAPs, whose size, shape, and composition, and heteroge-
neity thereof, depend strongly on the relative proportion of
M1 versus M23 AQP4. The model predicted key features of
AQP4 OAPs with minimal inputs on heterotetramer
AQP4 Orthogonal Arrays of Particles 2943composition, M23-M23 interaction, and OAP free energy.
Notably, the model did not require the inclusion of AQP4
interactions with other components, such as membrane
lipids or proteins, or soluble proteins, nor did it require
ascribing an active role to M1 AQP4 in limiting OAP size.
In addition to establishing AQP4 association rules and
providing an explanation for experimental observations on
OAPs, the model has clinical relevance to the human disease
NMO, where anti-AQP4 autoantibodies produce neuroin-
flammation and neurological impairment by binding to
AQP4-expressing astrocytes in spinal cord and optic nerve,
and, to a lesser extent, in brain (8,10,33,34). The model was
applied to investigate the mechanism by which NMO auto-
antibodies bind preferentially to M23 AQP4.
Our modeling approach involved the serial generation of
random AQP4 tetramers that were appended to a nascent
OAP by a matrix multiplication method in which all
possible binding locations and tetramer rotational orienta-
tions were probed. AQP4 tetramers composed of four M1
monomers were considered as unable to associate into
OAPs and were counted separately. An OAP was allowed
to grow by serial tetramer acquisitions until all possible
tetramer binding sites were occupied, or, in the constrained
model, if further OAP growth caused negative free energy to
exceed positive free energy. A completed OAP was then
analyzed for size, shape, and compositional parameters,
which were stored for subsequent number histogram gener-
ation and averaging. This serial tetramer/OAP generation
approach required minimal memory, with computation
time determined primarily by the random number genera-
tion and matrix multiplication operations. An alternative
modeling approach would involve the generation of a large
number of random tetramers and their parallel assembly into
a minimum free energy state. Though such free-energy-
based models could be useful for OAP modeling, they
would be computationally prohibitive and require difficult-
to-justify assumptions about parameters describing the
energy and entropy of all possible M1 and M23 interactions.
With a minimal set of input rules, the major model predic-
tions agreed with reported experimental data on OAPs and
with new experimental data generated in this study. The
inputs of the nonconstrained models included random
M1/M23 association in heterotetramers and intertetrameric
M23-M23 interaction but not M1-M23 or M1-M1 interac-
tion. Though the nonconstrained models allowed unre-
stricted OAP growth at high M23:M1 ratios and thus
could not quantitatively predict OAP size, the model accu-
rately predicted the observations of increased OAP size
with M23:M1 ratio, marked OAP size heterogeneity, OAP
size-dependent M1/M23 composition, and preferential
localization of M1 AQP4 at the periphery of OAPs. These
predictions were insensitive to the details of the association
rules in the nonconstrained models (optimal-association
versus random-association versus self-association varia-
tions). The predictions were also insensitive to the applica-tion of a free energy constraint in the constrained model,
which was required to prevent unrestricted OAP growth.
TIRF microscopy of GFP-AQP4 chimeras and native gel
electrophoresis were done on cells expressing different
M23:M1 ratios to test key predictions of the model. In
agreement with model predictions, the experimental data
showed increased OAP size with increasing M23:M1 ratio,
considerable OAP size heterogeneity at a fixed M23:M1
ratio, increased M23 versus M1 in larger OAPs, and prefer-
ential peripheral localization of M1 AQP4. The model also
predicted occasional defects in OAPs, in agreement with
freeze-fracture electron micrographs.
Notwithstanding the simplicity of the model and its
demonstrated predictive value, there are a number of caveats
and potential limitations. i), As described below, an empir-
ically deduced negative free energy term was required to
limit OAP size. ii), As a non-energy-based thermodynamic
model, as mentioned above, the model does not allow for
rearrangements in OAP geometry, as could occur spontane-
ously (22) or in response to regulatory factors (21) or
changes in M23 versus M1 expression (31). However, if
such changes are slow on the time-scale of AQP4 cellular
turnover then the present model would be applicable. iii),
The model does not account for the possibility of small
M1-only arrays, which have been occasionally seen by
FFEM inM1 AQP4-transfected cells (19,30,31). Such incip-
ient arrays are small in number compared to non-OAP-asso-
ciated M1 tetramers, and hence would be difficult to model
without inclusion of many additional assumptions. Further-
more, experimental evidence is lacking that these apparent
small arrays are composed exclusively of M1 AQP4. iv),
The model assumes heterotetrameric M1 and M23 associa-
tion, which is supported by experimental data from our labo-
ratory (21,22). An alternative possibility is that separate M1
and M23 homotetramers associate as hetero-hexadecimers.
It is noted that the model here, up to a size-scale factor, is
formally equivalent for M1/M23 heterotetramers and homo-
tetramer hetero-hexadecimers.
The constrained model required the generation of an
empirical negative free energy function to recapitulate
experimentally measured OAP sizes at different M23:M1
ratios. The idea is based on the second law of thermody-
namics, in which tetramer-OAP association results in
entropy loss, which must be balanced by a gain in free
energy to favor association. The positive (association) free
energy was determined by counting the number of
N-terminus interactions. However, theoretical quantification
of the negative free energy is not feasible. The entropy of
assembly contains translational, rotational, vibrational, and
conformational components (35). In previous reports on
entropy loss during macromolecular assembly, entropy
loss depends on multiple parameters, including its root
mean-squared amplitude (36), molecular weight (37), and
free volume (35,38), producing a total entropy loss that
increases in an approximately linear manner with theBiophysical Journal 100(12) 2936–2945
2944 Jin et al.number of molecules in an aggregate. For OAPs in biolog-
ical membranes, in addition to entropic contributions, the
negative free energy contains contributions of membrane
curvature, which is unfavorable to assembly of large
OAPs, as well as membrane crowding and AQP4 interac-
tions with various other cellular proteins and lipids. Our
modeling approach lumped together these ill-defined factors
into an empirically derived negative free energy function.
The model was also applied to investigate the differential
binding of NMO-IgG to M1 versus M23 AQP4. Several labs
have shown increased binding of NMO-IgG in NMO patient
serum to M23 versus M1 AQP4 (21,39,40). We recently re-
ported that introduction of an OAP-disrupting mutation in
M23 AQP4, which prevented OAP assembly, abolished
the enhanced NMO-IgG binding to M23 versus M1 AQP4
(28). Taken together with data showing that Fab fragments
generated from recombinant purified NMO-IgG retained
the difference in M23 versus M1 binding, we proposed
that OAP assembly by AQP4 alters the NMO-IgG binding
epitope(s) so as to increase binding affinity. Here, we
compared model predictions to quantitative measurements
of NMO-IgG binding to cells expressing AQP4 at a wide
range of M23:M1 ratios. Fifty percent enhancement of
NMO-IgG binding was found at M23:M1 ~ 0.2, with
maximal enhancement of ~6-fold at M23:M1 of 1:0. Model
predictions were in excellent agreement with experimental
data, providing quantitative support for our conclusion
about the AQP4 isoform-specific determinants of NMO-IgG
binding (28).
In conclusion, the relatively simple model of AQP4 asso-
ciation reported here recapitulated the major experimental
observations on OAP assembly. As more refined experi-
mental data become available on OAP size, shape, and
composition in live cells, perhaps by super-resolution
imaging methods, additional predictions of the model can
be tested and the model further refined. In addition to its
value in understanding the rules and determinants of
AQP4 OAP assembly, the model has utility, as demonstrated
in the one example here, in quantitative analysis of NMO-
IgG binding to AQP4 OAPs in the human neurological
disease, NMO.SUPPORTING MATERIAL
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